The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 78.
266. lappuse
... practice must be diligent from that date to the date of reduction to practice . If there is a gap in his diligence , his priority date goes back of his date of reduction to practice only as far as the beginning of the continuous period ...
... practice must be diligent from that date to the date of reduction to practice . If there is a gap in his diligence , his priority date goes back of his date of reduction to practice only as far as the beginning of the continuous period ...
267. lappuse
Howard I. Forman. REDUCTION TO PRACTICE AND EVIDENCE FOR ESTABLISHING REDUCTION TO PRACTICE The date of reduction to practice is of importance because it is not until this date that the invention is considered complete . It is a date of ...
Howard I. Forman. REDUCTION TO PRACTICE AND EVIDENCE FOR ESTABLISHING REDUCTION TO PRACTICE The date of reduction to practice is of importance because it is not until this date that the invention is considered complete . It is a date of ...
727. lappuse
... practice . The establishment of actual reduction to practice in a pharmaceutical case presents difficulties , especially in those cases where the interference count specifies a par- ticular use . Where an interference count involving a ...
... practice . The establishment of actual reduction to practice in a pharmaceutical case presents difficulties , especially in those cases where the interference count specifies a par- ticular use . Where an interference count involving a ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention